Login to Your Account



Financings Roundup

HC Royalty Inks Hefty Deals to Propel Nuron and Raptor

By Marie Powers
Staff Writer

Thursday, December 20, 2012

HealthCare Royalty Partners II LP closed an $80 million financing with Nuron Biotech Inc. that included a $30 million equity investment and a $50 million synthetic royalty agreement linked to future sales of Meningitec and its HibTiter vaccine (Haemophilus b conjugate vaccine [diphtheria CRM197 protein conjugate]).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription